Medicon Hellas SA 

€2.3
3
+€0.05+2.22% Thursday 13:45

统计数据

当日最高
-
当日最低
-
52周最高
-
52周最低
-
成交量
-
平均成交量
-
市值
16.44M
市盈率
21.75
股息收益率
2.61%
股息
0.06

即将到来

股息

2.61%股息收益率
10年增长
N/A
5年增长
N/A
3年增长
N/A
1年增长
N/A

收益

25Jun预期
Q3 2017
Q1 2024
0.29
0.62
0.96
1.29
预期每股收益
N/A
实际每股收益
N/A

人们还关注

此列表基于关注MEDIC.AT的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company imports and distributes analytical workstations for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems under the MLR name. It also produces instrument-specific and barcoded vial reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry reagents comprising control and calibration materials, and tests. In addition, the company engages in the production of cosmetic and skin care products under the Miss Beaute brand name. Further, it develops and sells software for laboratory and medical applications, and supplies IT systems to healthcare providers. Additionally, the company remanufactures and resells chemistry, hematology, blood gas, and immunochemistry analyzers; and provides contract remanufacturing and diagnostics laboratory services. Medicon Hellas S.A. was founded in 1988 and is headquartered in Gerakas, Greece.
Show more...
首席执行官
Mr. Dimotsantos S. Spyridon
员工
180
国家
Greece
ISIN
GRS424003002

上市公司